Literature DB >> 31840035

In vitro Intestinal Epithelial Wound-healing Assays Using Electric Cell-Substrate Impedance Sensing Instrument.

Olivier Merlin-Zhang1, Junsik Sung1, Emilie Viennois1.   

Abstract

Here, we describe an in vitro epithelial wound-healing assay using Electric Cell-Substrate Impedance Sensing (ECIS) technology. The ECIS technology is a real time cell growth assay based on a small (250 μm diameter) active gold electrode which resistance is measured continuously. When intestinal epithelial cells reach confluency on the gold electrode, resistances reach a plateau. For the wound-healing assays, confluent intestinal epithelial monolayers are subjected to a current of 40 kHz frequency, 1,400 μA amplitude, and 30-second duration. This kills the cells around the small active gold electrode, causing detachment and generating a wound that is healed by surrounding cells that have not been submitted to the current pulse. Wound healing is then assessed by continuous resistance measurements for approximately 30 h after wound. Both cell wounding and measurements of the subsequent healing process are carried out under computer control that takes online measurements each 30 s and stores the data. ECIS technology can be used to study the underlying causes for impaired mucosal healing and to test the efficacy of drugs in mucosal healing.

Entities:  

Keywords:  Caco2-BBE cells; Electric cell-substrate Impedance sensing; Intestinal epithelial cell Monolayers; Ulcerative colitis (UC); Wound-healing

Year:  2019        PMID: 31840035      PMCID: PMC6910258          DOI: 10.21769/BioProtoc.3351

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  3 in total

1.  ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers.

Authors:  Laetitia Charrier; Yutao Yan; Adel Driss; Christian L Laboisse; Shanthi V Sitaraman; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-09-09       Impact factor: 4.052

2.  TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.

Authors:  Bo Xiao; Qiubing Chen; Zhan Zhang; Lixin Wang; Yuejun Kang; Timothy Denning; Didier Merlin
Journal:  J Control Release       Date:  2018-08-11       Impact factor: 9.776

3.  Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

Authors:  Mingzhen Zhang; Emilie Viennois; Meena Prasad; Yunchen Zhang; Lixin Wang; Zhan Zhang; Moon Kwon Han; Bo Xiao; Changlong Xu; Shanthi Srinivasan; Didier Merlin
Journal:  Biomaterials       Date:  2016-06-09       Impact factor: 12.479

  3 in total
  3 in total

1.  PepT1-knockout mice harbor a protective metabolome beneficial for intestinal wound healing.

Authors:  Junsik Sung; Lixin Wang; Dingpei Long; Chunhua Yang; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-03-24       Impact factor: 4.052

2.  Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy.

Authors:  Cui Liu; Xiangji Yan; Yujie Zhang; Mei Yang; Yana Ma; Yuanyuan Zhang; Qiuran Xu; Kangsheng Tu; Mingzhen Zhang
Journal:  J Nanobiotechnology       Date:  2022-04-29       Impact factor: 9.429

3.  Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis.

Authors:  Chunhua Yang; Mingzhen Zhang; Sudeep Lama; Lixin Wang; Didier Merlin
Journal:  J Control Release       Date:  2020-04-23       Impact factor: 9.776

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.